United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69420-1001_e28f3c02-e3b3-44e6-895e-40f161d383c0
- Product NDC
- 69420-1001
- Form
- TABLET, FILM COATED
- Composition / generic term
- Cyclobenzaprine Hydrochloride
- Labeler
- SA3, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150325
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 7.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, FILM COATED in 1 BOTTLE (69420-1001-1) · 69420-1001-1
- 100 TABLET, FILM COATED in 1 BOTTLE (69420-1001-2) · 69420-1001-2
- 30 TABLET, FILM COATED in 1 BOTTLE (69420-1001-3) · 69420-1001-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →